SCHEMBL23830552

SCHEMBL23830552

CN(c1ccccc1)C1CNC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.41
SLC6A4 P31645 7/20 0.41
SLC6A3 Q01959 7/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
HTT P42858 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
BPTF Q12830 1/20 0.35
CTSD P07339 2/20 0.34
CHRM1 P11229 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2C P18825 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3619850 0.84 SLC6A4 (0.48) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL23255375 0.81 ALDH1A1 (0.44) SLC6A2SLC6A4SLC6A3HTR2CKCNH2
SCHEMBL1720308 0.79 HTT (0.41) HTTMEN1KMT2ADRD2HRH1
SCHEMBL28041570 0.79 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4010135 0.79 SLC18A3 (0.45) SLC6A2SLC6A4SLC6A3CYP2D6MEN1
Hydrochloric Acid SCHEMBL4389599 0.78 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3CYP2D6MEN1
Hydrochloric Acid SCHEMBL23292665 0.77 HTT (0.39) HTTMEN1KMT2ADRD2HRH1
SCHEMBL28096957 0.77 MEN1 (0.44) HTTMEN1KMT2AHRH1
SCHEMBL24375902 0.76 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL28531862 0.76 KCNH2 (0.42) CYP3A4CYP2D6CYP2C9CYP2C19CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883925-A1 CYCLIC UREAS Sironax Ltd (KY) 2021-09-29 EP disclosed
US-20210292305-A1 Cyclic Ureas SIRONAX LTD (KY) 2021-09-23 US disclosed
CN-113302183-A Cyclic ureas 圣瑞诺有限公司 2021-08-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292305-A1 Cyclic Ureas RIPK1, RIPK3, RIPK4 SLC6A2 4844/4885SLC6A4 4608/4885SLC6A3 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.